Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2014)

Safety and Immunogenicity of Two Doses of Quadrivalent Meningococcal Conjugate Vaccine or One Dose of Meningococcal Group C Conjugate Vaccine, both Administered Concomitantly with Routine Immunization to 12- to 18-Month-Old Children

  • Francisco Noya,
  • Deirdre McCormack,
  • Donna L Reynolds,
  • Dion Neame,
  • Philipp Oster

DOI
https://doi.org/10.1155/2014/237560
Journal volume & issue
Vol. 25, no. 4
pp. 211 – 216

Abstract

Read online

OBJECTIVES:To describe the immunogenicity and safety of a two-dose series of a quadrivalent meningococcal (serogroups A, C, Y and W) polysaccharide diphtheria toxoid conjugate vaccine (MenACYW-D) administered to toddlers.